Literature DB >> 16088837

Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests.

Joanne Baker1, James McCarthy, Michelle Gatton, Dennis E Kyle, Vicente Belizario, Jennifer Luchavez, David Bell, Qin Cheng.   

Abstract

Rising costs of antimalarial agents are increasing the demand for accurate diagnosis of malaria. Rapid diagnostic tests (RDTs) offer great potential to improve the diagnosis of malaria, particularly in remote areas. Many RDTs are based on the detection of Plasmodium falciparum histidine-rich protein (PfHRP) 2, but reports from field tests have questioned their sensitivity and reliability. We hypothesize that the variability in the results of PfHRP2-based RDTs is related to the variability in the target antigen. We tested this hypothesis by examining the genetic diversity of PfHRP2, which includes numerous amino acid repeats, in 75 P. falciparum lines and isolates originating from 19 countries and testing a subset of parasites by use of 2 PfHRP2-based RDTs. We observed extensive diversity in PfHRP2 sequences, both within and between countries. Logistic regression analysis indicated that 2 types of repeats were predictive of RDT detection sensitivity (87.5% accuracy), with predictions suggesting that only 84% of P. falciparum parasites in the Asia-Pacific region are likely to be detected at densities < or = 250 parasites/microL. Our data also indicated that PfHRP3 may play a role in the performance of PfHRP2-based RDTs. These findings provide an alternative explanation for the variable sensitivity in field tests of malaria RDTs that is not due to the quality of the RDTs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16088837     DOI: 10.1086/432010

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  142 in total

1.  Diagnostic potential of monoclonal antibodies developed against C-terminal polypeptide of P. falciparum Histidine Rich Protein2 (PfHRP2) in malaria infected patients from India.

Authors:  Reena Verma; Sara Chandy; N S Jayaprakash; Anand Manoharan; M A Vijayalakshmi; Krishnan Venkataraman
Journal:  Pathog Glob Health       Date:  2017-08-04       Impact factor: 2.894

2.  Performance of BinaxNOW for diagnosis of malaria in a U.S. hospital.

Authors:  Michael A Dimaio; Irma T Pereira; Tracy I George; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

3.  Recombinant antibodies specific for the Plasmodium falciparum histidine-rich protein 2.

Authors:  Elisabeth Ravaoarisoa; Halima Zamanka; Thierry Fusai; Jacques Bellalou; Hugues Bedouelle; Odile Mercereau-Puijalon; Thierry Fandeur
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

4.  Large variation in detection of histidine-rich protein 2 in Plasmodium falciparum isolates from Colombia.

Authors:  Zuleima Pava; Diego F Echeverry; Gustavo Díaz; Claribel Murillo
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

5.  False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene.

Authors:  Ousmane A Koita; Ogobara K Doumbo; Amed Ouattara; Lalla K Tall; Aoua Konaré; Mahamadou Diakité; Mouctar Diallo; Issaka Sagara; Godfred L Masinde; Safiatou N Doumbo; Amagana Dolo; Anatole Tounkara; Issa Traoré; Donald J Krogstad
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

6.  A General Synthetic Approach for Designing Epitope Targeted Macrocyclic Peptide Ligands.

Authors:  Samir Das; Arundhati Nag; JingXin Liang; David N Bunck; Aiko Umeda; Blake Farrow; Matthew B Coppock; Deborah A Sarkes; Amethist S Finch; Heather D Agnew; Suresh Pitram; Bert Lai; Mary Beth Yu; A Katrine Museth; Kaycie M Deyle; Bianca Lepe; Frances P Rodriguez-Rivera; Amy McCarthy; Belen Alvarez-Villalonga; Ann Chen; John Heath; Dimitra N Stratis-Cullum; James R Heath
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-17       Impact factor: 15.336

7.  Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.

Authors:  David J Bacon; Christine Latour; Carmen Lucas; Olga Colina; Pascal Ringwald; Stéphane Picot
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

8.  Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial.

Authors:  Hugh Reyburn; Hilda Mbakilwa; Rose Mwangi; Ombeni Mwerinde; Raimos Olomi; Chris Drakeley; Christopher J M Whitty
Journal:  BMJ       Date:  2007-01-26

Review 9.  Update on rapid diagnostic testing for malaria.

Authors:  Clinton K Murray; Robert A Gasser; Alan J Magill; R Scott Miller
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

10.  Insights into the Performance of SD Bioline Malaria Ag P.f/Pan Rapid Diagnostic Test and Plasmodium falciparum Histidine-Rich Protein 2 Gene Variation in Madagascar.

Authors:  Nigani Willie; Rajeev K Mehlotra; Rosalind E Howes; Tovonahary A Rakotomanga; Stephanie Ramboarina; Arsène C Ratsimbasoa; Peter A Zimmerman
Journal:  Am J Trop Med Hyg       Date:  2018-03-15       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.